Advanced search
1 file | 1.38 MB

Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling

(2015) CANCER RESEARCH. 75(16). p.3373-3383
Author
Organization
Keywords
GASTRIC-CANCER, INVASIVE GROWTH, HEPATOCYTE GROWTH-FACTOR, CANCER STEM-CELLS, ONCOGENE ADDICTION, C-MET, BREAST-CANCER, ENGINEERED ANTIBODY, DRUG-RESISTANCE, SCATTER-FACTOR

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.38 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Hultberg, Anna, Virginia Morello, Leander Huyghe, Natalie De Jonge, Christophe Blanchetot, Valérie Hanssens, Gitte de Boeck, et al. 2015. “Depleting MET-expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling.” Cancer Research 75 (16): 3373–3383.
APA
Hultberg, A., Morello, V., Huyghe, L., De Jonge, N., Blanchetot, C., Hanssens, V., de Boeck, G., et al. (2015). Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling. CANCER RESEARCH, 75(16), 3373–3383.
Vancouver
1.
Hultberg A, Morello V, Huyghe L, De Jonge N, Blanchetot C, Hanssens V, et al. Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling. CANCER RESEARCH. 2015;75(16):3373–83.
MLA
Hultberg, Anna et al. “Depleting MET-expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling.” CANCER RESEARCH 75.16 (2015): 3373–3383. Print.
@article{6971780,
  author       = {Hultberg, Anna and Morello, Virginia and Huyghe, Leander and De Jonge, Natalie and Blanchetot, Christophe and Hanssens, Valérie and de Boeck, Gitte and Silence, Karen and Festjens, Els and Heukers, Raimond and Roux, Benjamin and Lamballe, Fabienne and Ginestier, Christophe and Charafe-Jauffret, Emmanuelle and Maina, Flavio and Brouckaert, Peter and Saunders, Michael and Thibault, Alain and Dreier, Torsten and de Haard, Hans and Michieli, Paolo},
  issn         = {0008-5472},
  journal      = {CANCER RESEARCH},
  keywords     = {GASTRIC-CANCER,INVASIVE GROWTH,HEPATOCYTE GROWTH-FACTOR,CANCER STEM-CELLS,ONCOGENE ADDICTION,C-MET,BREAST-CANCER,ENGINEERED ANTIBODY,DRUG-RESISTANCE,SCATTER-FACTOR},
  language     = {eng},
  number       = {16},
  pages        = {3373--3383},
  title        = {Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling},
  url          = {http://dx.doi.org/10.1158/0008-5472.CAN-15-0356},
  volume       = {75},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: